A Study to Assess Variation in Potential Biomarkers in Friedreich Ataxia

ClinicalTrials.gov Identifier: NCT04255680, February 5, 2020
Intervention: Diagnostic Test: Buccal Swabs and Blood Draws
Sponsors: Chondrial Therapeutics, Inc.; Children's Hospital of Philadelphia. Enrolling by invitation

To test the variability of specific ribonucleic acid (RNA) and proteins as well as frataxin levels in samples of blood and buccal cells taken directly from patients with Friedreich's ataxia (FRDA) in order to confirm potential new biomarkers of disease in patients with FRDA.

A Study to Assess Variation in Potential Biomarkers in Friedreich Ataxia